Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

NCT07468513 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT07468513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07468513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Lead sponsor
Menzies School of Health Research
Phase
Phase 4
Overall status
Recruiting
Start date
May 17, 2024
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

g6pd deficiency, vivax malaria